Hospital for Special Surgery
New York, 10021, United States
NCT Number: NCT04084288
The majority of patients undergoing total knee replacement(TKR) rely on opioids for postoperative analgesia. These medications have undesirable side effects and potential for abuse and addiction. The aim of this cohort study is to determine the incidence rate of patients who are able to maintain a low dose opioid regimen after TKR with the use of a multimodal approach that includes intraoperative auricular acupuncture protocol.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
New York, 10021, United States
This is a prospective cohort study to assess the feasibility of patients to undergo TKR while adhering to a low-dose opioid regimen by using a multimodal analgesic approach that includes intraoperativeauricular acupuncture. We hypothesize that it will be feasible to maintain a low-dose opioid regimen during TKR while followingthe intraoperative auricular acupuncture protocol, and that patients will be satisfied with their pain control with a low incidence of adverse events.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ipsilateral Auricular Trauma Protocol (ATP) acupuncture at eight ear points (Hypothalamus, Amygdala, Hippocampus, Prefrontal Cortex, Point Zero, Shen Men, Insula, Vagus) with 30Hz electrostimulation at two of those points (Shen Men and Hypothalamus). Acupuncture needles will be left in place and stimulated for 60 min and then removed
Ipsilateral Auricular Trauma Protocol (ATP) acupuncture at eight ear points (Hypothalamus, Amygdala, Hippocampus, Prefrontal Cortex, Point Zero, Shen Men, Insula, Vagus) with 30Hz electrostimulation at two of those points (Shen Men and Hypothalamus).
Time frame: postoperative day 0 to postoperative day 30
The number of patients who maintain a low-dose opioid regimen (15 pills or less of 5mg oxycodone or 112.5 OME [oral morphine equivalents]) from postoperative day (POD) 0 to POD 30 throughout their Total Knee Replacement.
Time frame: post anesthesia care unit (PACU), postoperative day (POD) 1, POD7, POD14, POD30
Postoperative opioid consumption measured in oral morphine equivalents (OME) at various timepoints
Time frame: post anesthesia care unit (PACU), postoperative day (POD) 1, POD7, POD14, POD30
Numerical Rating Scale (NRS) pain scores at rest and with movement. NRS pain is measured from 0 to 10, with 0 being the no pain whatsoever and 10 being the worst pain imaginable.
Time frame: postoperative day 1
Duration of neuraxial anesthesia is defined as number of hours between anesthesia start time to anesthesia stop time.
Time frame: Postoperative day 30
Tracking the number of patients that received different oral pain main medication, including the need for rescue medications by postoperative day 30
Time frame: PACU, Postoperative day 1
Incidence of nausea, vomiting, pruritus (itching), and constipation. These are reported by the patient in the PACU and on postoperative day 1
Time frame: 6 weeks postoperative (surgeon office visit)
Postoperative range of motion measured at the 6 week surgeon office visit. This is being measured by either the physician or their PA and is a score that is achieved by adding extension and flexion together. It is measured in degrees. (example: flexion: 118 + extension:1 = score: 119)
Time frame: Intraoperatively
Duration of time the tourniquet is inflated intraoperatively. Measured in minutes
Hospital for Special Surgery, New York
Other
Intraoperative Acupuncture for Low-Dose Opioid Total Knee Replacement: An Observational Prospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04749628
Arthritis, Joint Diseases
New York, United States
View Trial DetailsNCT05924412
Acute Pain, Agnosia
Santiago, Metropolitan, Chile
View Trial DetailsNCT04859283
Arthritis, Joint Diseases
Turku, Finland
View Trial DetailsNCT04471233
Arthritis, Joint Diseases
Great Neck, New York, United States
View Trial Details